Login
Home / 4431.TWO : TWO
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Mytrex Health Technologies, Inc.

TWD 20.05 +$2.75 (+15.90%)
TWO · 16 Sep 2026 03:37 UTC
Previous Close
TWD 19.9
Day Range
TWD 19.5TWD 20.05
Year Range
TWD 15.6TWD 23.1
Market Cap
732.54M
AVG Volume
50.27K
Trailing/Forward PE
-143.21/-
PEG ratio
-0.7
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Taipei ExchangeTW
Revenue (TWD)
0500M1B1.5B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (TWD)
-100M-75M-50M-25M025M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (TWD)
-60M-40M-20M020M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (TWD)
-50M050M100M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (TWD)
-100M0100M200M21 Q221 Q422 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EPS (TWD)
-3-2-10121 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (TWD)
0100M200M300MR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (TWD)
0200M400M600M800MCashLong Term DebtShort Term Debt21 Q221 Q422 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
-15-10-5051021 Q221 Q422 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
0%5%10%15%20%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Return on Capital
-15%-10%-5%0%5%21 Q221 Q422 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
010M20M30M40M21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Dividends (TWD)
0246Sep 12Sep 13Aug 14Aug 15Aug 16Aug 17Aug 18Aug 19Aug 20Sep 21
Book Value Per Share (TWD)
010203021 Q221 Q422 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (TWD)
0500M1B1.5B21 Q221 Q422 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
PE Ratio
02.557.51012.5med 3.07Jun 21Oct 21Jan 22May 22Aug 22Dec 22Mar 23
Free Cash Flow Yield
0%10%20%30%40%50%med 16.22%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
0.150.20.250.30.350.4med 0.2Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
010203040med 25.68Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
123456med 3.55Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
0.811.21.41.6med 1.13Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Mytrex Health Technologies, Inc.
4431.TWO
Stockpicker

Video analysis: 4431.TWO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.